Belgium· BE-AMP-SAM042077-00

Uralyt-U

A urinary concrement solvents product containing trisodium citrate dihydrate, registered in Belgium by Viatris Healthcare. The same ATC class is registered in 5 of our 19 countries.

ATC G04BC

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedUralyt-UATCG04BCREGISTER NO.BE-AMP-SAM042077-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Trisodium citrate dihydrate is registered in 5 of 19 countries.

Countries holding a registration under ATC G04BC (urinary concrement solvents), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose

Trisodium citrate dihydrate · ATC G04BC

5 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Trisodium Citrate Dihydrate
Manufacturer
Viatris Healthcare
Country
Belgium (BE)
ATC code
G04BC
ATC class
Urinary concrement solvents
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0093518

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Trisodium citrate dihydrate in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trisodium citrate dihydrate products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Canesoasis Cystitis Relief, Care Cystitis Relief
  • Italy · Sodio Citrato S.A.L.F.
  • Portugal · Citrato De Sódio 3,8%, Citrato De Sódio 5,0%

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/63dc5a06-a3c8-4cd9-9aba-65e321fcc424
GET /v1/drugs/63dc5a06-a3c8-4cd9-9aba-65e321fcc424?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Granules",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Uralyt-U",
  "name_fr": "Uralyt-U",
  "name_nl": "Uralyt-U",
  "amp_code": "SAM042077-00",
  "strengths": [
    "39.0000",
    "39.0000",
    "46.0000",
    "14.8000",
    "14.8000",
    "46.0000",
    "0.0070"
  ],
  "pack_count": 1,
  "substances": [
    "Trisodium Citrate Dihydrate",
    "Tripotassium Citrate Monohydrate",
    "Citric Acid",
    "E 110"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Urinary Concrement Solvents",
  "authorisation_numbers": [
    "BE042077"
  ]
}

See everything about trisodium citrate dihydrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.